EFung Capital logo

EFung Capital

Asia, Guangdong, China, Shenzhen

Description

Shenzhen EFUNG Investment Management Enterprise is an institution that invests in professional biomedical industries.

Investor Profile

EFung Capital has backed more than 12 startups, with 5 new investments in the last 12 months alone. The firm has led 4 rounds, about 33% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, India.
  • Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.
  • Led 3 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Series Unknown (17%)
  • Series C (17%)
  • Angel (8%)
  • Series B (8%)

Country Focus

  • China (75%)
  • United States (17%)
  • India (8%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
  • Biopharma
  • Battery
  • Electric Vehicle
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EFung Capital frequently co-invest with?

Hyde Capital
North America, California, United States, Santa Monica
Co-Investments: 1
China Capital Management
Asia, Beijing, China, Beijing
Co-Investments: 1
RI
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Alteria Capital
Asia, Maharashtra, India, Mumbai
Co-Investments: 1
Avaana Capital
Asia, Maharashtra, India, Mumbai
Co-Investments: 1
V
North America, California, United States, San Mateo
Co-Investments: 2
HT Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 2
Tigermed
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

Which angels does EFung Capital often collaborate with?

Shared Deals: 1

What are some of recent deals done by EFung Capital?

Tingsheng Technology

Nanjing, Jiangsu, China

Tingsheng Technology develops intra cardiac ultrasound ICE products.

Health CareMedical Device
Series BJun 25, 2025
Amount Raised: $13,943,695
QureBio

Shanghai, Shanghai, China

QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals.

BiotechnologyHealth CareMedicalPharmaceutical
Series CJun 5, 2025
Amount Raised: $13,935,340
Novlead Biotech

Nanjing, Jiangsu, China

Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.

BiotechnologyHealth CareMedicalPharmaceutical
Series CApr 15, 2025
Shineyo Medical

Shanghai, Shanghai, China

Shineyo Medical is a provider of minimally invasive cardiovascular interventional treatment devices.

Health CareMedicalMedical Device
Series AApr 2, 2025
Suzhou Meichuang

Suzhou Shi, Jiangsu, China

Meichuang focuses on the innovative R&D, manufacturing and commercialization of high-end medical devices.

MedicalMedical Device
Series AJan 15, 2025
Amount Raised: $13,640,518
Turno

Bengaluru, Karnataka, India

Turno is an automobile company that provides 3 wheeled electric vehicles and financing to customers.

BatteryElectric VehicleFinancial ServicesFinTech
Series AFeb 9, 2023
Amount Raised: $13,570,535
TriArm Therapeutics

Beijing, Beijing, China

TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.

BiotechnologyHealth Care
Series UnknownSep 27, 2021
Amount Raised: $60,000,000
3D Medicines

Minhang, Shanghai, China

3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownOct 9, 2020
Amount Raised: $140,000,000
TriArm Therapeutics

Beijing, Beijing, China

TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.

BiotechnologyHealth Care
Series AJul 19, 2019
Amount Raised: $20,000,000
Tactiva Therapeutics

Buffalo, New York, United States

Tactiva Therapeutics is a development stage immuno-oncology company

BiotechnologyOncology
Series ADec 3, 2018
Amount Raised: $35,000,000